期刊
BRITISH JOURNAL OF CANCER
卷 104, 期 6, 页码 1007-1012出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2011.33
关键词
osteopontin; colorectal cancer; metastasis; hepatectomy
类别
资金
- Cancer Research UK Research Training Bursary [C19075/A6164]
- Academy of Medical Sciences (AMS) [AMS-CSF3-Mole] Funding Source: researchfish
BACKGROUND: A transcription regulatory complex (TRC) that includes Ets1, Ets2, PEA3 and beta-catenin/T-cell factors regulates osteopontin (OPN) that is implicated in colorectal cancer (CRC) dissemination. The consistency of OPN transcriptional control between primary CRC and metastases is unclear. This study investigates expression and prognostic significance of the OPN-TRC in primary human CRC and associated colorectal liver metastases (CRLM). METHODS: Osteopontin-TRC factors were assayed by digital microscopy in 38 primary CRCs and matched CRLM specimens and assessed against clinical prognosis. RESULTS: In primary CRC, OPN expression intensity correlated with that of its co-activators, PEA3 (r = 0.600; P<0.01), Ets1 (r = 0.552; P<0.01), Ets2 (r =.521; P<0.01) and had prognostic significance. Osteopontin intensity in primary CRC inversely correlated with the interval between diagnosis and resection of CRLM. Overall OPN intensity was lower in CRLM than primary CRC and correlations with co-activators were weaker, for example, Ets1 (P=0.047), PEA3 (P 0.022) or nonsignificant (Ets2). The ratio of OPN expression in CRLM vs primary CRC had prognostic significance. CONCLUSION: This study supports transcriptional control of OPN by known coregulators in both primary and secondary CRC. Weaker associations in CRLM suggest involvement of other unknown factors possibly from the liver microenvironment or resulting from additional genetic or epigenetic changes that drive tumour metastatic capability in OPN transcriptional control. British Journal of Cancer (2011) 104, 1007-1012. doi: 10.1038/bjc.2011.33 www.bjcancer.com
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据